Xtant Medical Holdings, Inc. financial data

Symbol
XTNT on NYSE
Industry
Biological Products, (No Diagnostic Substances)
Location
664 Cruiser Lane, Belgrade, MT
State of incorporation
DE
Fiscal year end
December 31
Former names
Bacterin International Holdings, Inc. (to 8/3/2015), K KITZ INC (to 5/21/2010)
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 240 % -9.74%
Quick Ratio 139 % +9.92%
Debt-to-equity 101 % +19.9%
Return On Equity -37.1 % -613%
Return On Assets -18.5 % -571%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 139M shares +6.84%
Common Stock, Shares, Outstanding 139M shares +6.85%
Entity Public Float 25.8M USD +269%
Weighted Average Number of Shares Outstanding, Basic 135M shares +5.43%
Weighted Average Number of Shares Outstanding, Diluted 135M shares -0.42%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 114M USD +45.1%
Research and Development Expense 2.36M USD +119%
Selling and Marketing Expense 49.1M USD +50.3%
General and Administrative Expense 31.9M USD +52.1%
Operating Income (Loss) -14M USD -73.3%
Nonoperating Income (Expense) -2.85M USD -133%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -16.8M USD -3469%
Income Tax Expense (Benefit) 743K USD
Net Income (Loss) Attributable to Parent -17.6M USD -739%
Earnings Per Share, Basic -0.12 USD/shares -700%
Earnings Per Share, Diluted -0.12 USD/shares -700%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.6M USD -23.9%
Accounts Receivable, after Allowance for Credit Loss, Current 20.5M USD +7.29%
Inventory, Net 41.9M USD +22%
Assets, Current 71.4M USD +11.4%
Property, Plant and Equipment, Net 10.3M USD +13%
Operating Lease, Right-of-Use Asset 995K USD -37.6%
Intangible Assets, Net (Excluding Goodwill) 8.79M USD -16.2%
Goodwill 7.3M USD +12.1%
Other Assets, Noncurrent 103K USD -48.2%
Assets 98.9M USD +7.48%
Accounts Payable, Current 8.3M USD +54.9%
Accrued Liabilities, Current 8.87M USD -0.71%
Liabilities, Current 33.7M USD +53.6%
Deferred Income Tax Liabilities, Net 21K USD
Operating Lease, Liability, Noncurrent 247K USD -73%
Other Liabilities, Noncurrent 38K USD
Liabilities 53.2M USD +42.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 54K USD
Retained Earnings (Accumulated Deficit) -256M USD -7.37%
Stockholders' Equity Attributable to Parent 45.7M USD -16.4%
Liabilities and Equity 98.9M USD +7.48%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.76M USD -156%
Net Cash Provided by (Used in) Financing Activities 5.18M USD +13.4%
Net Cash Provided by (Used in) Investing Activities -674K USD +96.1%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 139M shares +6.85%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.3M USD +91.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 7.09M USD -19%
Interest Paid, Excluding Capitalized Interest, Operating Activities 740K USD +45.4%
Deferred Tax Assets, Valuation Allowance 25.8M USD +24%
Deferred Tax Assets, Gross 26.6M USD +24.9%
Operating Lease, Liability 1.59M USD +11.1%
Depreciation 2.4M USD +71.4%
Payments to Acquire Property, Plant, and Equipment 773K USD +69.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -17.4M USD -153%
Lessee, Operating Lease, Liability, to be Paid 1.72M USD +9.85%
Property, Plant and Equipment, Gross 31.3M USD +11.3%
Operating Lease, Liability, Current 795K USD +8.46%
Lessee, Operating Lease, Liability, to be Paid, Year Two 680K USD +21.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 918K USD +71.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 128K USD -3.76%
Lessee, Operating Lease, Liability, to be Paid, Year Three 119K USD -74.7%
Deferred Tax Assets, Operating Loss Carryforwards 18.6M USD +35.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 302M USD +2.87%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 1.7M USD 0%
Depreciation, Depletion and Amortization 1.01M USD +113%
Interest Expense 3.2M USD +67.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%